Literature DB >> 23226100

CCN6 knockdown disrupts acinar organization of breast cells in three-dimensional cultures through up-regulation of type III TGF-β receptor.

Anupama Pal1, Wei Huang, Kathy A Toy, Celina G Kleer.   

Abstract

While normal cells in the human breast are organized into acinar structures, disruption of the acinar architecture is a hallmark of cancer. In a three-dimensional model of morphogenesis, we show that down-regulation of the matrix-associated tumor suppressor protein CCN6 (WNT1-inducible-signaling pathway protein 3) disrupts breast epithelial cell polarity and organization into acini through up-regulation of the type III transforming growth factor-β receptor (TβRIII or betaglycan). Down-regulation of CCN6 in benign breast cells led to loss of tissue polarity and resulted in cellular disorganization with loss of α6 integrin-rich basement membrane and the basolateral polarity protein E-cadherin. Silencing of TβRIII with shRNA and siRNA rescued the ability of breast epithelial cells to form polarized acinar structures with reduced matrix invasion and restored the correct expression of α6 integrin and E-cadherin. Conversely, CCN6 overexpression in aggressive breast cancer cells reduced TβRIII in vitro and in a xenograft model of CCN6 overexpression. The relevance of our studies to human breast cancer is highlighted by the finding that CCN6 protein levels are inversely associated with TβRIII protein in 64%of invasive breast carcinomas. These results reveal a novel function of the matricellular protein CCN6 and establish a mechanistic link between CCN6 and TβRIII in maintaining acinar organization in the breast.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23226100      PMCID: PMC3514738          DOI: 10.1593/neo.121322

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  20 in total

1.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

Authors:  Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

2.  CCN6 modulates BMP signaling via the Smad-independent TAK1/p38 pathway, acting to suppress metastasis of breast cancer.

Authors:  Anupama Pal; Wei Huang; Xin Li; Kathy A Toy; Zaneta Nikolovska-Coleska; Celina G Kleer
Journal:  Cancer Res       Date:  2012-07-17       Impact factor: 12.701

Review 3.  The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay.

Authors:  V M Weaver; A H Fischer; O W Peterson; M J Bissell
Journal:  Biochem Cell Biol       Date:  1996       Impact factor: 3.626

4.  The type III TGF-beta receptor suppresses breast cancer progression.

Authors:  Mei Dong; Tam How; Kellye C Kirkbride; Kelly J Gordon; Jason D Lee; Nadine Hempel; Patrick Kelly; Benjamin J Moeller; Jeffrey R Marks; Gerard C Blobe
Journal:  J Clin Invest       Date:  2006-12-07       Impact factor: 14.808

5.  The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.

Authors:  Ryan S Turley; Elizabeth C Finger; Nadine Hempel; Tam How; Timothy A Fields; Gerard C Blobe
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

6.  WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer.

Authors:  Celina G Kleer; Yanhong Zhang; Quintin Pan; Sofia D Merajver
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

7.  Betaglycan presents ligand to the TGF beta signaling receptor.

Authors:  F López-Casillas; J L Wrana; J Massagué
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

8.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.

Authors:  Celina G Kleer; Qi Cao; Sooryanarayana Varambally; Ronglai Shen; Ichiro Ota; Scott A Tomlins; Debashis Ghosh; Richard G A B Sewalt; Arie P Otte; Daniel F Hayes; Michael S Sabel; Donna Livant; Stephen J Weiss; Mark A Rubin; Arul M Chinnaiyan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

9.  WISP3 is a novel tumor suppressor gene of inflammatory breast cancer.

Authors:  Celina G Kleer; Yanhong Zhang; Quintin Pan; Kenneth L van Golen; Zhi-Fen Wu; D Livant; Sofia D Merajver
Journal:  Oncogene       Date:  2002-05-09       Impact factor: 9.867

10.  Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells.

Authors:  Yanhong Zhang; Quintin Pan; Hui Zhong; Sofia D Merajver; Celina G Kleer
Journal:  Breast Cancer Res       Date:  2005-11-08       Impact factor: 6.466

View more
  16 in total

1.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

2.  A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer.

Authors:  Sabra I Djomehri; Boris Burman; Maria E Gonzalez; Shuichi Takayama; Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2018-12-04       Impact factor: 5.782

3.  Three dimensional cultures: a tool to study normal acinar architecture vs. malignant transformation of breast cells.

Authors:  Anupama Pal; Celina G Kleer
Journal:  J Vis Exp       Date:  2014-04-25       Impact factor: 1.355

4.  Characterization of type III TGF-β receptor expression in invasive breast carcinomas: a potential new marker and target for triple negative breast cancer.

Authors:  Judy C Pang; Nilam K Virani; Kelley M Kidwell; Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2014-08-19       Impact factor: 5.782

Review 5.  Matricellular CCN6 (WISP3) protein: a tumor suppressor for mammary metaplastic carcinomas.

Authors:  Mai N Tran; Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2018-01-22       Impact factor: 5.782

6.  The matricellular protein CCN6 differentially regulates mitochondrial metabolism in normal epithelium and in metaplastic breast carcinomas.

Authors:  Mai Tran; Shoshana A Leflein; Maria E Gonzalez; Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2021-11-22       Impact factor: 5.908

7.  Dual roles of CCN proteins in breast cancer progression.

Authors:  Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2016-08-12       Impact factor: 5.782

8.  CCN family of proteins: critical modulators of the tumor cell microenvironment.

Authors:  Herman Yeger; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2016-08-12       Impact factor: 5.782

Review 9.  Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities.

Authors:  Izabela Krupska; Elspeth A Bruford; Brahim Chaqour
Journal:  Hum Genomics       Date:  2015-09-23       Impact factor: 4.639

10.  Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway.

Authors:  Harish Potu; Luke F Peterson; Anupama Pal; Monique Verhaegen; Juxiang Cao; Moshe Talpaz; Nicholas J Donato
Journal:  Oncotarget       Date:  2014-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.